Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Selvita Reports Rebound in H2 2024 and 11% Increase in Backlog for 2025
      Biotech

      Selvita Reports Rebound in H2 2024 and 11% Increase in Backlog for 2025

      March 27, 2025
      Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology
      Biotech

      Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology

      March 27, 2025
      Antengene to Present Results From Four Cutting Edge Preclinical Studies at AACR 2025 with Focuses Including AnTenGagerTM TCEs and Synthetic Lethality
      Biotech

      Antengene to Present Results From Four Cutting Edge Preclinical Studies at AACR 2025 with Focuses Including AnTenGagerTM TCEs and Synthetic Lethality

      March 26, 2025
      IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 (GSK959), a Phase 1 Werner Helicase Inhibitor
      Biotech

      IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 (GSK959), a Phase 1 Werner Helicase Inhibitor

      March 26, 2025
      BioArctic’s partner Eisai presents sales simulation for Leqembi® at its annual press conference
      Biotech

      BioArctic’s partner Eisai presents sales simulation for Leqembi® at its annual press conference

      March 25, 2025
      TFS HealthScience Appoints Miriam Martin as Vice President of Business Development, Clinical Development Services
      Biotech

      TFS HealthScience Appoints Miriam Martin as Vice President of Business Development, Clinical Development Services

      March 25, 2025
      Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
      Biotech

      Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

      March 24, 2025
      WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year
      Biotech

      WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year

      March 24, 2025
      Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson’s Disease
      Biotech

      Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson’s Disease

      March 24, 2025
      Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients
      Biotech

      Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients

      March 22, 2025
      « 1 … 40 41 42 43 44 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026